(Total Views: 168)
Posted On: 02/01/2022 1:35:49 PM
Post# of 107319

$JAGX News Article - Jaguar Health Announces Completion of Third-party, Investigator-Initiated Study of Crofelemer, which is Expected to Support Orphan Drug Designation (ODD) for Crofelemer for Congenital Diarrheal Disorders (CDD) https://marketwirenews.com/news-releases/jagu...48999.html


My Twitter: WhyteStocks